Neuren Pharmaceuticals | NEU - Gross Profit On Sales

Stock Price
12.52
Daily Change
-0.68 -5.15%
Monthly
-31.51%
Yearly
-10.70%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD6.69M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.95M 1.18M Jun/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Dianthus Therapeutics USD 396K 203K Sep/2025
Genetic Signatures AUD 4.75M 190K Dec/2024
Ionis Pharmaceuticals USD 155M 293M Sep/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organon & Co USD 857M 17M Sep/2025
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Starpharma Holdings AUD -736K 2.82M Jun/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024
Viatris USD 1.37B 38.6M Sep/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025